| Autor: |
Seiko N. Doi, Jens Jakob Thune, Jens C. Nielsen, Jens Haarbo, Lars Videbæk, Adelina Yafasova, Niels E. Bruun, Finn Gustafsson, Hans Eiskjær, Christian Hassager, Jesper H. Svendsen, Dan E. Høfsten, Christian Torp‐Pedersen, Steen Pehrson, Lars Køber, Jawad H. Butt |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 3 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2047-9980 |
| DOI: |
10.1161/JAHA.123.031977 |
| Popis: |
Background Patients with heart failure and chronic kidney disease (CKD) may have an increased risk of death from causes competing with arrhythmic death, which could have implications for the efficacy of implantable cardioverter‐defibrillators (ICDs). We examined the long‐term effects of primary prophylactic ICD implantation, compared with usual care, according to baseline CKD status in an extended follow‐up study of DANISH (Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality). Methods and Results In the DANISH trial, 1116 patients with nonischemic heart failure with reduced ejection fraction were randomized to receive an ICD (N=556) or usual care (N=550). Outcomes were analyzed according to CKD status (estimated glomerular filtration rate ≥/ |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text